• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

十种肝功能模型在接受射频消融治疗的肝细胞癌患者中的预后性能。

Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation.

机构信息

Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.

出版信息

Sci Rep. 2018 Jan 16;8(1):843. doi: 10.1038/s41598-018-19251-y.

DOI:10.1038/s41598-018-19251-y
PMID:29339752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5770426/
Abstract

Liver functional capacity is a crucial survival determinant for hepatocellular carcinoma (HCC). Noninvasive models were proposed to assess hepatic reserve, but their performance in outcome prediction is unclear. We aimed to investigate 10 currently used liver function models in HCC patients undergoing radiofrequency ablation (RFA). A total 499 HCC patients were prospectively identified. Homogeneity and corrected Akaike information criteria (AICc) were compared. Cox proportional hazards model was used to identify independent survival predictors. Significance survival differences were found across 10 noninvasive models (all p < 0.001) except for GUCI and APRI grade 2 vs 3, and King's score grade 1 vs 2. Among these models, ALBI grade showed the highest homogeneity and lowest AICs value, indicating a better prognostic performance. Within Child-Turcotte-Pugh (CTP) score 5 group, significant survival difference was demonstrated between ALBI grade 1 and 2 (p < 0.001); for those with CTP score 6 or higher, only ALBI grade 2 and 3 showed survival difference (p < 0.001). Cox analysis disclosed that ALBI grade, tumor size and performance status were independent prognostic predictors. There was significant correlation between CTP score and other 9 models. We conclude that ALBI grade may serve as objective and feasible surrogate for prognostic prediction in HCC patients undergoing RFA.

摘要

肝功能是肝细胞癌(HCC)患者生存的关键决定因素。目前已经提出了一些非侵入性模型来评估肝储备功能,但其在预后预测方面的性能尚不清楚。本研究旨在探讨 10 种目前用于接受射频消融(RFA)治疗的 HCC 患者的肝功能模型。前瞻性纳入 499 例 HCC 患者。比较了同质性和校正后的 Akaike 信息准则(AICc)。使用 Cox 比例风险模型来确定独立的生存预测因素。在 10 种非侵入性模型中均发现了显著的生存差异(均 p<0.001),但 GUCI 和 APRI 分级 2 与 3 以及 King 评分分级 1 与 2 除外。在这些模型中,ALBI 分级显示出最高的同质性和最低的 AICs 值,表明其预后性能更好。在 Child-Turcotte-Pugh(CTP)评分 5 组中,ALBI 分级 1 和 2 之间的生存差异显著(p<0.001);对于 CTP 评分 6 或更高的患者,只有 ALBI 分级 2 和 3 之间的生存差异显著(p<0.001)。Cox 分析显示,ALBI 分级、肿瘤大小和体能状态是独立的预后预测因素。CTP 评分与其他 9 种模型之间存在显著相关性。综上所述,ALBI 分级可能作为接受 RFA 治疗的 HCC 患者预后预测的客观、可行的替代指标。

相似文献

1
Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation.十种肝功能模型在接受射频消融治疗的肝细胞癌患者中的预后性能。
Sci Rep. 2018 Jan 16;8(1):843. doi: 10.1038/s41598-018-19251-y.
2
Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.使用白蛋白-胆红素分级对极早期肝细胞癌患者射频消融治疗后的肝功能评估
Dig Dis Sci. 2017 Nov;62(11):3235-3242. doi: 10.1007/s10620-017-4775-8. Epub 2017 Oct 5.
3
Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.非侵入性肝储备标志物在接受经动脉化疗栓塞的肝细胞癌患者中的预后作用
PLoS One. 2017 Jul 3;12(7):e0180408. doi: 10.1371/journal.pone.0180408. eCollection 2017.
4
Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection.比较 12 种肝储备功能模型在肝癌手术切除患者预后预测中的应用。
Sci Rep. 2018 Mar 19;8(1):4773. doi: 10.1038/s41598-018-22923-4.
5
Comparison Between Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Assessing the Prognosis of Hepatocellular Carcinoma After Stereotactic Ablative Radiation Therapy.儿童-托卡德-普格评分与白蛋白-胆红素评分在评估立体定向消融放疗后肝细胞癌预后中的比较
Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):145-152. doi: 10.1016/j.ijrobp.2017.04.036. Epub 2017 May 3.
6
Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma.白蛋白-胆红素分级预测肝癌极早期/早期行肝切除术与射频消融术的疗效。
Surgeon. 2018 Jun;16(3):163-170. doi: 10.1016/j.surge.2017.07.003. Epub 2017 Aug 12.
7
Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma.结合客观肝脏储备评估的改良CLIP对晚期肝细胞癌患者仍具有预后预测价值。
J Gastroenterol Hepatol. 2016 Jul;31(7):1336-41. doi: 10.1111/jgh.13312.
8
ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.在终末期肝病模型(MELD)时代,ALBI和PALBI分级可预测不同治疗方式和巴塞罗那临床肝癌(BCLC)分期的肝细胞癌患者的生存率。
J Gastroenterol Hepatol. 2017 Apr;32(4):879-886. doi: 10.1111/jgh.13608.
9
Albumin - bilirubin (ALBI) versus Child-Turcotte-Pugh (CTP) in prognosis of HCC after stereotactic body radiation therapy.白蛋白-胆红素(ALBI)与 Child-Turcotte-Pugh(CTP)在立体定向体部放射治疗后 HCC 预后中的比较。
Radiat Oncol. 2019 Mar 27;14(1):50. doi: 10.1186/s13014-019-1251-y.
10
Radiofrequency ablation is better than surgical resection in patients with hepatocellular carcinoma within the Milan criteria and preserved liver function: a retrospective study using propensity score analyses.对于符合米兰标准且肝功能良好的肝细胞癌患者,射频消融术优于手术切除:一项使用倾向评分分析的回顾性研究。
J Clin Gastroenterol. 2015 Mar;49(3):242-9. doi: 10.1097/MCG.0000000000000133.

引用本文的文献

1
Development and validation of a prealbumin-bilirubin model for prognostic prediction in intermediate hepatocellular carcinoma undergoing transarterial chemoembolization.用于经动脉化疗栓塞的中期肝细胞癌预后预测的前白蛋白-胆红素模型的开发与验证
Sci Rep. 2025 May 25;15(1):18147. doi: 10.1038/s41598-025-02960-6.
2
Machine learning-based model for predicting tumor recurrence after interventional therapy in HBV-related hepatocellular carcinoma patients with low preoperative platelet-albumin-bilirubin score.基于机器学习的模型,用于预测术前血小板-白蛋白-胆红素评分低的 HBV 相关肝细胞癌患者介入治疗后肿瘤复发。
Front Immunol. 2024 May 28;15:1409443. doi: 10.3389/fimmu.2024.1409443. eCollection 2024.
3

本文引用的文献

1
Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia.用于低病毒载量慢性乙型肝炎患者肝脏疾病严重程度和肝细胞癌风险的非侵入性检测方法。
Liver Int. 2018 Jan;38(1):68-75. doi: 10.1111/liv.13489. Epub 2017 Jul 3.
2
ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.在终末期肝病模型(MELD)时代,ALBI和PALBI分级可预测不同治疗方式和巴塞罗那临床肝癌(BCLC)分期的肝细胞癌患者的生存率。
J Gastroenterol Hepatol. 2017 Apr;32(4):879-886. doi: 10.1111/jgh.13608.
3
The FIB-4 index is a significant prognostic factor in patients with non-B non-C hepatocellular carcinoma after curative surgery.
Albumin‑bilirubin grade and INR for the prediction of esophagogastric variceal rebleeding after endoscopic treatment in cirrhosis.
白蛋白-胆红素分级和国际标准化比值用于预测肝硬化内镜治疗后食管胃静脉曲张再出血
Exp Ther Med. 2023 Sep 11;26(5):501. doi: 10.3892/etm.2023.12200. eCollection 2023 Nov.
4
Modified Albumin-Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy.用于对接受抗癌治疗的肝细胞癌患者生存情况进行分层的改良白蛋白-胆红素模型
Cancers (Basel). 2022 Oct 17;14(20):5083. doi: 10.3390/cancers14205083.
5
Platelet-albumin-bilirubin score - a predictor of outcome of acute variceal bleeding in patients with cirrhosis.血小板-白蛋白-胆红素评分——肝硬化患者急性静脉曲张出血预后的预测指标
World J Hepatol. 2020 Mar 27;12(3):99-107. doi: 10.4254/wjh.v12.i3.99.
6
Relationship between platelet-based models and the prognosis of patients with malignant hepatic tumors.基于血小板的模型与恶性肝肿瘤患者预后的关系。
Oncol Lett. 2020 Mar;19(3):2384-2396. doi: 10.3892/ol.2020.11317. Epub 2020 Jan 17.
7
Nomogram based on albumin-bilirubin grade to predict outcome of the patients with hepatitis C virus-related hepatocellular carcinoma after microwave ablation.基于白蛋白-胆红素分级的列线图预测丙型肝炎病毒相关肝细胞癌患者微波消融后的预后
Cancer Biol Med. 2019 Nov;16(4):797-810. doi: 10.20892/j.issn.2095-3941.2018.0486.
8
Mitofusin-2 acts as biomarker for predicting poor prognosis in hepatitis B virus related hepatocellular carcinoma.线粒体融合蛋白2作为预测乙型肝炎病毒相关肝细胞癌预后不良的生物标志物。
Infect Agent Cancer. 2018 Nov 26;13:36. doi: 10.1186/s13027-018-0212-7. eCollection 2018.
9
Pretreatment Inflammation-Based Markers Predict Survival Outcomes in Patients with Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation.基于预处理炎症的标志物预测射频消融治疗后早期肝细胞癌患者的生存结局。
Sci Rep. 2018 Nov 9;8(1):16611. doi: 10.1038/s41598-018-34543-z.
10
A model combining TNM stage and tumor size shows utility in predicting recurrence among patients with hepatocellular carcinoma after resection.一种结合TNM分期和肿瘤大小的模型在预测肝细胞癌患者切除术后的复发方面显示出实用性。
Cancer Manag Res. 2018 Sep 20;10:3707-3715. doi: 10.2147/CMAR.S175303. eCollection 2018.
FIB-4指数是根治性手术后非B非C型肝细胞癌患者的重要预后因素。
Langenbecks Arch Surg. 2016 Mar;401(2):195-203. doi: 10.1007/s00423-016-1389-0. Epub 2016 Mar 4.
4
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.基于证据的肝细胞癌患者诊断、分期和治疗。
Gastroenterology. 2016 Apr;150(4):835-53. doi: 10.1053/j.gastro.2015.12.041. Epub 2016 Jan 12.
5
Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.白蛋白-胆红素分级对2584例日本肝细胞癌患者预后评估的价值
J Gastroenterol Hepatol. 2016 May;31(5):1031-6. doi: 10.1111/jgh.13250.
6
The Kings Score refines prognostic prediction in hepatocellular carcinoma: a novel application.金斯评分法优化了肝细胞癌的预后预测:一项新应用。
Liver Int. 2015 Nov;35(11):2458-65. doi: 10.1111/liv.12841. Epub 2015 May 11.
7
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study.肝细胞癌从诊断到死亡的全球管理模式:BRIDGE研究
Liver Int. 2015 Sep;35(9):2155-66. doi: 10.1111/liv.12818. Epub 2015 Mar 25.
8
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
9
Utility of the FIB-4 Index for hepatocarcinogenesis in hepatitis C virus carriers with normal alanine aminotransferase levels.FIB-4指数在丙氨酸氨基转移酶水平正常的丙型肝炎病毒携带者肝癌发生中的应用价值。
J Viral Hepat. 2015 Oct;22(10):777-83. doi: 10.1111/jvh.12389. Epub 2015 Jan 21.
10
Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.肝细胞癌患者肝功能评估:一种基于新证据的方法——ALBI分级
J Clin Oncol. 2015 Feb 20;33(6):550-8. doi: 10.1200/JCO.2014.57.9151. Epub 2014 Dec 15.